Welcome to our dedicated page for ISPIRE TECHNOLOGY news (Ticker: ISPR), a resource for investors and traders seeking the latest updates and insights on ISPIRE TECHNOLOGY stock.
Ispire Technology Inc. (ISPR) delivers innovative vaping solutions through its Aspire e-cigarettes and cannabis vaporization systems. This news hub provides investors and industry professionals with essential updates on technological advancements, regulatory developments, and strategic partnerships shaping the alternative consumption market.
Access real-time announcements including quarterly earnings reports, product launch details, and manufacturing innovations. Our curated collection features press releases about precision dosing breakthroughs, ODM collaborations with global brands, and expansions into new international markets.
Stay informed about ISPR's progress in cannabis vaporization technology, patent filings, and compliance initiatives. The archive serves as a strategic resource for analyzing market trends and corporate milestones in the evolving vaping sector.
Bookmark this page for direct access to verified corporate communications. Combine regular monitoring with fundamental analysis tools to track ISPR's position in the competitive landscape of reduced-risk nicotine and cannabis delivery systems.
Ispire Technology (NASDAQ: ISPR) has announced a groundbreaking development in vaping safety through its joint venture IKE Tech. The company has filed the first-ever PMTA and TPMF with the FDA for a blockchain-enabled age-verification system designed for ENDS devices. The innovative BLE System-on-a-Chip requires continuous, real-time age verification for device access, achieving 100% effectiveness in preventing underage usage and demographic verification in testing.
The technology demonstrated impressive results in Human Factors Validation Study, including user error rates below 1% and 91% user satisfaction. IKE Tech has requested expedited FDA review, citing public health benefits. The submission follows a successful pre-PMTA meeting with the FDA in Q4 2024, where regulators showed openness to component-based PMTAs.
The system aims to create an FDA-authorized standard for youth prevention while maintaining adult access to reduced-risk alternatives, potentially opening new pathways for flavored vaping products.Ispire Technology Inc. (NASDAQ: ISPR) joint venture, IKE Tech , has announced groundbreaking results from their Human Factors Validation Study of the first blockchain-based age-gating system for electronic nicotine delivery systems (ENDS). The study evaluated their Bluetooth Low Energy (BLE) System, which combines biometric authentication and blockchain technology.
Key findings from the study of 101 participants showed:
- 100% successful age verification rate
- Complete prevention of underage device activation
- 100% device deactivation after inactivity
- 91% of users rated the app as extremely or very easy to use
- Only 1% error rate in task attempts
The IKE System, developed through a partnership between Ispire, Berify, and Chemular, aims to establish new regulatory standards for ENDS manufacturers while ensuring adult-only access. The platform features customizable elements including geofencing, authentication protection, and real-time messaging capabilities.
Ispire Technology Inc. (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has announced its participation in the upcoming Planet MicroCap Showcase. The event will be held from April 22-24, 2025, at the Paris Hotel and Casino in Las Vegas, Nevada.
Jim McCormick, Chief Financial Officer, is scheduled to deliver a live presentation on Wednesday, April 23, 2025, at 9:30am PST / 12:30pm EST on Track 5 – Concorde A. The presentation will be available via live webcast. Additionally, the company's management team will be conducting one-on-one meetings with investors throughout the conference.
Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has announced its participation in the upcoming 37th Annual ROTH Conference in Dana Point, California, scheduled for March 16-18, 2025.
Co-CEO Michael Wang will engage in a fireside chat on Tuesday, March 18, 2025, at 1:00pm PST / 4:00pm EST, which will be available via live webcast. The company's management team will also conduct one-on-one meetings with institutional investors throughout the conference.
Ispire Technology Inc. (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has announced its participation in the upcoming 37th Annual ROTH Conference scheduled for March 16-18, 2025, in Dana Point, California.
The company issued a correction regarding the timing of Co-CEO Michael Wang's fireside chat, which will take place on Tuesday, March 18, 2025, at 10:00am PST / 1:00pm EST, not at 1:00pm PST as previously stated. The discussion will be available via live webcast.
During the conference, management will also conduct one-on-one meetings with institutional investors. Interested parties can arrange meetings through ROTH MKM or by contacting ispire@kcsa.com.
Ispire Technology Inc. (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has announced its participation in the upcoming Webull Consumer Webinar Series scheduled for February 18, 2025, at 3:00 p.m. ET. Michael Wang, Co-CEO, will be presenting at the event.
The announcement comes amid several significant recent developments for the company, including:
- Release of fiscal second quarter 2025 financial results (February 10, 2025)
- Implementation of a stock repurchase program (January 22, 2025)
- Successful launch of Burna Boy's BrkFst nicotine products in African markets (January 15, 2025)
- Introduction of the VLT pod system for enhanced 510-thread vaping (November 25, 2024)
- Positive pre-PMTA submission meeting with the FDA in collaboration with IKE Tech (November 18, 2024)
Ispire Technology (NASDAQ: ISPR) reported fiscal Q2 2025 results with revenue of $41.8 million, a slight increase of 0.3% year-over-year. Gross profit rose 23.5% to $7.7 million, with gross margins improving to 18.5% from 15.0%. However, operating expenses increased 48% to $15.1 million, resulting in a net loss of $8.0 million ($0.14 per share), compared to a $4.0 million loss in Q2 2024.
The company expanded internationally with its BrkFst brand launching in Africa, establishing presence in over 500 retail locations across South Africa and Nigeria. The company plans to reach 2,000 stores in six months. In Malaysia, Ispire obtained nicotine import/export licenses and expects to scale to 70 production lines. The Board authorized a $10 million stock repurchase program, and the company projects $8 million in annual cost savings from Malaysian operations restructuring.
Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has scheduled its fiscal second quarter 2025 earnings conference call for Monday, February 10, 2025, at 8:00am ET. The call will discuss financial results for the quarter ended December 31, 2024.
Participants can join via phone using the following dial-in numbers: 877-451-6152 (US) or +1 201-389-0879 (International). The call will also be broadcast live online at the company's webcasting platform. A replay will be available from 11:00 am ET on February 10 through February 24, 2025, accessible by dialing 844-512-2921 or +1 412-317-6671 with passcode 13751256.
Ispire Technology (NASDAQ: ISPR) has announced a significant stock repurchase program, with its Board of Directors approving the repurchase of up to $10 million of common stock over the next 24 months. The company, which specializes in vaping technology and precision dosing, will conduct repurchases through various means, including open market transactions, accelerated buyback programs, tender offers, and private negotiations.
Co-CEO Michael Wang emphasized that this decision reflects confidence in the company's overall business growth and strategic investments. The company highlighted that improved margin expansion has enabled this capital return initiative. The repurchase program can be executed under Rule 10b5-1 and may be modified, suspended, or discontinued at any time based on market conditions, share price, and other factors.